Contact

Insights

The latest news in radiology AI

Understand the latest developments in AI image quantification

See how our software is supporting clinicians in healthcare institutions across the world, and meet the patients benefitting from precision volumetric analysis.

Filter by

Solution

Topic

Disease

  • < 1 mins

18 November 2023

Auto CT registration improves sensitivity to ventricular volume change

Study: Retrospective evaluation of ventricular shunt or EVD patients assessing reader ability to discern change with & without automated CT registration.

  • < 1 mins

18 November 2023

Prospective longitudinal MRI study of brain changes after TBI

Prospective study of Traumatic Brain Injury (TBI) patients to investigate volumes and diffusion changes during the first year after moderate-to-severe TBI.

  • < 1 mins

18 November 2023

Amygdala volume changes in PTSD-affected veterans

Study: The effect of PTSD on volumetric changes in the amygdala/hippocampus and of the contribution of illness duration, trauma load, & depressive symptoms. 

  • < 1 mins

18 November 2023

Quantitative MR volumetry in temporal lobe epilepsy

NeuroQuant® quantitative MR imaging can enhance standard visual analysis, empowering translation of volumetric analysis into clinical practice.

  • < 1 mins

18 November 2023

Mesial temporal sclerosis accuracy: NeuroQuant® vs. neuroradiologist

Study: Published in the American Journal of Neuroradiology, this study compares the accuracy of a fully automated assessment versus a manual interpretation.

  • < 1 mins

18 November 2023

Volumetric quantification of focal atrophy in AD

Volumetric analysis of structural MR images of the brain may provide evidence of neurodegeneration and help identify patients at risk for rapid deterioration.

  • < 1 mins

18 November 2023

Structural, functional & molecular neuroimaging biomarkers for AD

  • < 1 mins

18 November 2023

Biomarkers for the clinical evaluation of cognitive impairment

Research in Imaging in Medicine argues tests for amyloid when used in isolation are clinically useful only when evidence suggests progressive cognitive decline.

  • < 1 mins

18 November 2023

Neuroimaging in the evaluation of memory impairment

Authors Rahul Desikan et al from UCSD and UCSF describe a strategy to incorporate newly available imaging markers in the workup of memory problems

  • < 1 mins

18 November 2023

Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers

  • < 1 mins

18 November 2023

Mild cognitive impairment: improving predictive prognosis

Published in Radiology, this study assesses whether volumetric magnetic resonance (MR) imaging measures provide predictive prognostic information.

  • < 1 mins

18 November 2023

The contribution of MRI in assessing cognitive impairment in multiple sclerosis

Our solutions

Advanced AI tools tailored for improved disease prediction and monitoring.

View all solutions

AI radiology news

Stay up to date with the latest insights, advances and clinical applications

Subscribe
“Utilizing NeuroQuant® in our health system has provided invaluable information, which leads to improved patient care.”

Dr. Ana Franceschi

Associate Professor, Radiology, Neuro-PET Imaging Lenox Hill Hospital

“NeuroQuant® is the clinical gold standard for MRI brain volume measurement.”

Dr. David E. Ross

Director, Virginia Institute of Neuropsychiatry

“Adding NeuroQuant® to our clinics has led to earlier diagnoses of neurodegenerative diseases with increased diagnostic confidence.”

Dr. Pablo Coimbra

Fortaleza General Hospital

“NeuroQuant® allows radiologists to quantify localized brain atrophy in minutes and compare to a large database of normal controls, which was previously not possible in a routine clinical setting.”

Dr. Sunil K. Ram

Neuroradiologist, Scottsdale Medical Imaging

Empowering precision

and clarity in patient care

5060 Shoreham Place,
Ste 240, San Diego, CA 92122

  • Solutions
  • © Cortechs.ai 2024
Scroll to Top